Delivery of loaded MR1 Monomer Results in Efficient Ligand Exchange to Host MR1 and Subsequent MR1T cell activation
C. A. Kulicke, G. M. Swarbrick, N. A. Ladd, M. Cansler, M. Null, A. Worley, C. Lemon, T. Ahmed, J. Bennett, T. N. Lust, C. M. Heisler, M. E. Huber, J. R. Krawic, L. M. Ankley, S. K. McBride, F. G. Tafesse, A. Olive, W. H. Hildebrand, D. A. Lewinsohn, E. J. Adams, D. M. Lewinsohn, M. J. Harriff
Abstract
MR1-restricted T cells have been implicated in microbial infections, sterile inflammation, wound healing and cancer. Similar to other antigen presentation molecules, evidence supports multiple, complementary MR1 antigen presentation pathways. To investigate ligand exchange pathways for MR1, we used MR1 monomers and tetramers loaded with 5-(2-oxopropylideneamino)-6-d-ribitylaminouracil (5-OP-RU) to deliver the antigen. Using MR1-deficient cells reconstituted with wild-type MR1 or MR1 molecules that cannot bind 5-OP-RU, we show that presentation of monomer-delivered 5-OP-RU is dependent on cellular MR1 and requires the transfer of ligand from the soluble molecule onto MR1 expressed by the antigen presenting cell. This mode of antigen delivery strengthens the evidence for post-ER ligand exchange pathways for MR1, which could represent an important avenue by which MR1 acquires antigens derived from endocytosed pathogens.
02 /Specification & Classification
Click any tag to browse matching papers- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mutations outside the MR1 antigen binding groove differentially inhibit presentation of exogenous antigens
Corinna A. Kulicke, Chance Lemon, … David Michael Lewinsohn·Journal of Biological ChemistryPeer-reviewed·Feb 26, 2026
- Selective inhibition of MR1-restricted T cell activation by a novel MR1-targeting nanobody
Timothy Bates, Corinna A. Kulicke, … Fikadu Tafesse·bioRxiv·Jun 11, 2025
- Specific targeting of MR1-antigen complexes using nanobodies
Hisham S. Hussain, Samuel J. Redmond, … Nicholas A. Gherardin·Science ImmunologyPeer-reviewed·Sep 25, 2026
- Sorting endosomes play key roles in presentation of Mycobacterium tuberculosis-derived ligands to MAIT cells
Allison E. Tammen, Jessie C. Peterson, … Elham Karamooz·Scientific ReportsPeer-reviewed·May 29, 2026
- Deaza-modification of MR1 ligands modulates recognition by MR1-restricted T cells
H. Jin, N. A. Ladd, … M. Harriff·bioRxiv·May 11, 2022
- A miniaturized MR1 metabolite display system with native-like protein features
Photis Rotsides, Omkar Shinde, … Nikolaos G. Sgourakis·bioRxiv·Apr 15, 2026